North Hollywood, CA, October 22, 2014 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – congratulates its Chairman and Co-Founder Brian G.M. Durie, MD, on being honored with the Distinguished Alumni Award from Mayo Clinic. Dr. Durie, who completed residencies and fellowships at Mayo Clinic, was honored at a ceremony in Rochester, MN on October 20, 2014 for his “exceptional contributions” to the field of myeloma.
“It is an honor to receive Mayo Clinic’s Distinguished Alumni Award,” said Dr. Durie. “The time I spent learning and practicing at Mayo Clinic was invaluable in shaping my career and my focus on myeloma. I am indebted to the researchers I worked with during those years for their insight, collegiality, and support.”
Each year since 1981, Mayo Clinic’s Board of Trustees has given Distinguished Alumni Awards to individuals who have been recognized nationally, and often internationally, in their fields of medicine. Dr. Durie is only the second person to be honored for his work in blood cancer, following myeloma pioneer Dr. Robert Kyle.
“I am extremely proud of Dr. Durie, as is the IMF,” said Susie Novis, IMF President and Co-Founder. “This is truly a well-deserved honor and recognizes Dr. Durie’s substantial contributions to the body of myeloma knowledge, which benefit the entire myeloma community. The work he does will continue to have a major impact on myeloma treatment, management, and, most importantly, the cure for this disease.”
Dr. Durie serves as the Chairman of the IMF’s International Myeloma Working Group (IMWG) and leads the IMF’s Black Swan Research Initiative®, a collaborative research initiative to find a cure for myeloma.
Dr. Durie won the Leukemia Society of America Scholar award in 1976, and was also the US Hematologic Research Foundation Annual Awardee. In 2002, he won the Society of Nuclear Medicine and Molecular Imaging’s annual first-prize award for Best Clinical Medicine Study for his paper on whole-body FDG/PET scanning in myeloma. Dr. Durie received the 2006 Robert A. Kyle Lifetime Achievement Award, an award from the IMF that honors a physician whose body of work in the field of myeloma has made significant advances in research, treatment, and care of myeloma patients. In 2009, Dr. Durie won the Waldenström’s Research Award in recognition of his many contributions to the field of multiple myeloma. In 2011, Dr. Durie was awarded the Joseph Michaeli Award from Weill Cornell Comprehensive Cancer Center for outstanding contributions to the treatment of myeloma.
Dr. Durie has authored more than 400 research papers, 16 book chapters, and five books on multiple myeloma and related conditions. He co-created the Durie/Salmon Staging System, which is used worldwide for evaluating patients with myeloma. Dr. Durie is also a marquee member of "Who's Who in America" and "The Best Doctors in America."
ABOUT THE INTERNATIONAL MYELOMA FOUNDATION
Established in 1990, the International Myeloma Foundation (IMF) is the oldest and largest foundation focusing specifically on multiple myeloma. The Foundation’s reach extends to more than 350,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure by focusing on four key areas: research, education, support, and advocacy. The IMF has conducted more than 250 educational seminars worldwide, maintains a world-renowned InfoLine, and in 2001, established the International Myeloma Working Group (IMWG), a collaborative research initiative focused on improving myeloma treatment options for patients. In 2013, the IMF launched the Black Swan Research Initiative®, a groundbreaking research project aimed at curing myeloma. The IMF can be reached at (800) 452-CURE (2873). The global website is www.myeloma.org. Follow the IMF on Twitter @IMFmyeloma.